Erwin Tomasich
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 7
-
- Epigenetics and DNA Methylation 5
- Cancer-related gene regulation 3
- Co-authors
- Gerwin Heller (22 shared papers)Maximilian Marhold (10 shared papers)Michael Krainer (9 shared papers)Peter Horak (6 shared papers)Reinhard Horvat (3 shared papers)Christoph Minichsdorfer (4 shared papers)Leonhard Müllauer (7 shared papers)Sabine Zöchbauer‐Müller (4 shared papers)
In The Last Decade
Erwin Tomasich
30 papers receiving 576 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 165
- Oncology 155
- Molecular Biology 290
- Pulmonary and Respiratory Medicine 98
- Immunology 64
Countries citing papers authored by Erwin Tomasich
This map shows the geographic impact of Erwin Tomasich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin Tomasich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin Tomasich more than expected).
Fields of papers citing papers by Erwin Tomasich
This network shows the impact of papers produced by Erwin Tomasich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin Tomasich. The network helps show where Erwin Tomasich may publish in the future.
Co-authors
The 25 scholars most cited alongside Erwin Tomasich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 113 | |
| 2 | 2014 | 77 | |
| 3 | 2014 | 48 | |
| 4 | 2020 | 45 | |
| 5 | 2015 | 41 | |
| 6 | 2021 | 37 | |
| 7 | 2019 | 30 | |
| 8 | 2018 | 29 | |
| 9 | 2015 | 25 | |
| 10 | 2014 | 23 | |
| 11 | 2022 | 20 | |
| 12 | 2023 | 16 | |
| 13 | 2019 | 12 | |
| 14 | 2024 | 11 | |
| 15 | 2020 | 11 | |
| 16 | 2022 | 10 | |
| 17 | 2022 | 8 | |
| 18 | 2022 | 5 | |
| 19 | 2022 | 4 | |
| 20 | 2022 | 3 |
About Erwin Tomasich
Erwin Tomasich is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 32 papers that have together received 580 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (3 papers), Glioma Diagnosis and Treatment (3 papers), Ferroptosis and cancer prognosis (2 papers), Cancer Genomics and Diagnostics (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Galectins and Cancer Biology (2 papers). The work is most often cited by research in Cancer Research (165 citations), Oncology (155 citations), Molecular Biology (290 citations), Pulmonary and Respiratory Medicine (98 citations) and Immunology (64 citations). Erwin Tomasich has collaborated with scholars based in Austria, Germany and Hungary. Frequent co-authors include Gerwin Heller, Maximilian Marhold, Michael Krainer, Peter Horak, Reinhard Horvat, Christoph Minichsdorfer, Leonhard Müllauer, Sabine Zöchbauer‐Müller, Barbara Ziegler and Christoph Zielinski. Their work appears in journals such as Clinical Cancer Research, Journal for ImmunoTherapy of Cancer, Oncotarget, Annals of Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.